Learn about LIBTAYO® (cemiplimab-rwlc) in the treatment of advanced NSCLC, BCC, CSCC, & as an adjuvant treatment for high-risk CSCC. Review Important Safety Info & Full Prescribing Information …

LIBTAYO, an immunotherapy, may help with certain kinds of cancer. LIBTAYO is a treatment that works by blocking cancer cells from binding with PD-1. This enables T cells to detect cancer cells and …

Learn about LIBTAYO® (cemiplimab-rwlc) for the treatment of advanced CSCC. Review Important Safety Info & Full Prescribing Information including Med Guide.

LIBTAYO is a prescription medicine used to treat adults with a type of skin cancer called basal cell carcinoma (BCC) that: Cannot be removed by surgery (locally advanced BCC) or when it has spread …

Learn about LIBTAYO® (cemiplimab-rwlc) in the treatment of advanced non-small cell lung cancer (NSCLC). Review Important Safety Info & Full Prescribing Information including Med Guide.

LIBTAYO as a single agent is indicated for the first-line treatment of adult patients with NSCLC whose tumors have high PD-L1 expression [Tumor Proportion Score (TPS) ≥ 50%] as determined by an …

How will I receive LIBTAYO? LIBTAYO is a medicine prescribed by a doctor. It is given in a hospital or clinic as a 30-minute intravenous (IV) infusion. That means it enters the body through a vein. What is …

Meaningful stories. Meaningful hope. It can be helpful and inspiring to hear the experiences of people living with advanced CSCC and their treatment with LIBTAYO. LIBTAYO is a prescription medicine …

The treatment options for NSCLC are based mainly on the stage and extent of the cancer. Other factors, such as your overall health and lung function, as well as certain traits of the cancer itself, are also …

LIBTAYO resources Get more information about LIBTAYO and how it may be an appropriate treatment option for your advanced cutaneous squamous cell carcinoma (CSCC). LIBTAYO downloadable …